Literature DB >> 5010705

The treatment of patients with interstitial cystitis, with special reference to intravesical DMSO.

B H Stewart, A C Branson, C B Hewitt, W S Kiser, R A Straffon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5010705     DOI： 10.1016/s0022-5347(17)61032-2

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  4 in total

1.  Measuring the success of combined intravesical dimethyl sulfoxide and triamcinolone for treatment of bladder pain syndrome/interstitial cystitis.

Authors:  Adam Gafni-Kane; Sylvia M Botros; Hongyan Du; Robert I Sand; Peter K Sand
Journal:  Int Urogynecol J       Date:  2012-06-15       Impact factor: 2.894

2.  Intravesical chemotherapy: combination with dimethyl sulfoxide does not enhance cytotoxicity in vitro.

Authors:  L Walker; M C Walker; C N Parris; J R Masters
Journal:  Urol Res       Date:  1988

3.  Relative cytotoxicities of adriamycin and epirubicin in combination with lonidamine against human bladder cancer cell lines.

Authors:  R J Popert; J R Masters; M Coptcoat; G Zupi
Journal:  Urol Res       Date:  1995

Review 4.  Therapeutic Efficacy of onabotulinumtoxinA Delivered Using Various Approaches in Sensory Bladder Disorder.

Authors:  Po-Yen Chen; Wei-Chia Lee; Hung-Jen Wang; Yao-Chi Chuang
Journal:  Toxins (Basel)       Date:  2020-01-23       Impact factor: 4.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.